President Donald Trump has repeatedly taken aim at drug makers for contributing to the nation's runaway health care spending.
Now he's setting his sights on insurers, hospitals and other providers as a way to achieve one of his top promises -- lowering costs for consumers.
The administration is considering requiring these players to disclose the rates they privately negotiate, an idea that has sparked a backlash from the influential industry.
